What causes snoring and why treating it improves both partners' sleep

What causes snoring: Mechanical, anatomical, and lifestyle factors

What causes snoring when sleeping is a combination of upper airway narrowing and tissue vibration during breathing. When you inhale during sleep, air flows through a narrowed passage, causing the soft palate, uvula, tongue base, and pharyngeal walls to vibrate and produce sound. The question is what makes that passage narrow in the first place.

A 2026 systematic review found that neck circumference, obesity, age, and sex all independently predict airway obstruction during sleep.¹ These are anatomical risk factors, meaning they change the physical dimensions of the airway. Neck circumference above 40 cm in men or 37 cm in women correlates with fat deposition around the pharynx, which compresses the airway from the outside. Obesity contributes through multiple pathways: excess adipose tissue in the tongue and lateral pharyngeal walls, increased abdominal mass that reduces lung volume, and systemic inflammation that may worsen airway collapsibility.²

The mechanical interaction between the lungs and upper airway also matters. Reduced lung volume pulls less traction on the trachea, which reduces the caudal (downward) force that normally helps hold the upper airway open. This explains why sleep position influences snoring: supine (back) sleeping reduces functional residual capacity and allows the tongue to fall backward, doubling the collapse risk.³⁴

Lifestyle factors add to the risk. Alcohol relaxes pharyngeal dilator muscles and blunts the arousal response to airway obstruction. A 2024 cohort study found that alcohol use disorder increased obstructive sleep apnea risk by 25% after adjusting for BMI and age.⁵ Smoking causes upper airway inflammation and edema, increasing airway resistance even in the absence of obesity.

What causes snoring in females vs males: How risk factors differ

What causes snoring in females differs from what causes snoring in men in both prevalence and underlying mechanisms. Before menopause, women have a lower snoring prevalence than men at every BMI level, a difference that disappears after menopause.¹ This points to a protective effect of estrogen and progesterone, which maintain pharyngeal muscle tone and reduce the propensity for airway collapse.

The anatomical threshold for obstruction also differs by sex. Men typically have longer, more collapsible airways with greater soft tissue volume in the tongue base and lateral pharyngeal walls. Women who snore are more likely to have a mixed anatomical and neuromuscular phenotype: a structurally smaller airway combined with reduced responsiveness of the genioglossus muscle (which protrudes the tongue forward to prevent collapse).²

Body fat distribution matters more than total obesity for women. Central adiposity (waist circumference) predicts snoring in women more strongly than BMI alone, because visceral fat increases airway resistance through lung volume reduction and inflammatory mediators. Neck circumference, the strongest single predictor in men, is less predictive in women until the threshold exceeds 37 cm.¹

Pregnancy creates a distinct risk window: fluid retention increases upper airway edema, progesterone-driven hyperventilation increases upper airway resistance, and weight gain compounds the effect. Snoring onset during pregnancy often resolves postpartum but signals increased risk for sleep-disordered breathing later in life.

Snoring fragments your partner’s sleep all night, not just when they wake

Popular advice often frames snoring as a problem only when it wakes the bed partner. The evidence shows continuous sleep fragmentation even when the partner does not consciously wake. A 2020 objective acoustic study measured snoring sound pressure levels in the bed partner’s ear position and found peaks of 60 to 80 dB (equivalent to moderate traffic or a dishwasher running at close range) occurring on average 20 to 60 times per hour.⁶ These sounds triggered cortical arousals (brief EEG accelerations) without full awakening, fragmenting the partner’s sleep architecture.

The perceptual features of snoring matter as much as the decibel level. A 2022 study analyzing snore-related sounds found that intensity variability, spectral irregularity, and abrupt onset predicted which sounds disrupted partner sleep.⁷ Snoring is not white noise. It has unpredictable timing, variable pitch, and sudden crescendos that prevent habituation. The partner’s brain cannot “tune out” the sound because the unpredictability triggers vigilance.

The result is measurable sleep deprivation. Bed partners of snorers average 1 to 2 hours less sleep per night and report higher rates of daytime fatigue, irritability, and depressive symptoms.¹² Separate bedrooms eliminate the acoustic disruption but create a different tension, which brings us to the feedback loop.

The feedback loop: Why relationship quality determines treatment success

The advice to “just sleep in separate rooms” treats snoring as a purely individual medical problem. The evidence reveals a dyadic feedback loop: relationship quality predicts whether the snorer will adhere to treatment, and successful treatment improves relationship satisfaction in both partners.

A 2019 prospective cohort study followed 125 patients prescribed CPAP (continuous positive airway pressure) for obstructive sleep apnea. Baseline marital quality and partner engagement (the partner’s active participation in encouraging treatment and troubleshooting adherence barriers) predicted 6-month CPAP adherence more strongly than disease severity or sleepiness scores.¹⁰ Couples with high baseline relationship satisfaction had 73% adherence at 6 months, compared to 39% adherence in couples reporting relationship distress.

The mechanism runs in both directions. A 2025 cross-sectional study found that dyadic adjustment (the couple’s ability to adapt together to the illness) mediated the relationship between sleep quality and CPAP adherence.¹¹ When both partners framed sleep apnea as a shared problem requiring mutual adjustment, treatment adherence improved. When the snorer perceived the treatment as an individual burden or the partner disengaged out of frustration, adherence dropped.

The payoff for sustained treatment is not just better sleep. A 2026 randomized trial found that 3 months of CPAP improved marital relationship quality and sexual satisfaction scores in both the patient and the bed partner, with effect sizes comparable to those seen with couples therapy.⁹ The mechanism appears to be multifactorial: reduced sleep fragmentation for the partner, improved mood and energy for the snorer, and the shared accomplishment of navigating treatment together.

This creates the feedback loop. Couples who disengage (separate bedrooms, minimal communication about the problem) remove the immediate sleep disruption but lose the relational motivation that predicts treatment success. Couples who stay engaged get better treatment outcomes, which then reinforces relationship quality.

Which treatments help both partners: Mandibular devices vs CPAP

The standard advice defaults to CPAP for moderate to severe obstructive sleep apnea and lifestyle modification for primary snoring. The randomized trial evidence complicates this tidy division.

A 2024 randomized clinical trial compared mandibular advancement devices (MADs) to combined airway and positional therapy in 120 patients with habitual snoring. At 3 months, MAD reduced snoring frequency by 48% and improved bed partner sleep quality scores by 34%, significantly better than combined therapy.¹³ A 2015 crossover RCT found similar results: MADs reduced snoring index (snores per hour) from 250 to 88 on average, and 68% of bed partners reported subjectively improved sleep quality.¹⁴

CPAP is more effective at eliminating apneas (complete airway collapse events) but has worse adherence. A 2019 review of CPAP adherence predictors found that 30 to 50% of patients prescribed CPAP abandon it within the first year.¹⁶ The partner’s reaction to the device matters: visible discomfort, mask noise, and reduced spontaneity during sleep all strain the relationship. Yet for couples who adapt, CPAP produces larger improvements in partner-reported relationship and sexual satisfaction than MADs, likely because it addresses apnea-related hypoxia and arousals more completely.⁹

An umbrella review of oral appliance therapy (MADs, tongue-retaining devices) concluded that MADs are effective for mild to moderate obstructive sleep apnea and primary snoring, with adherence rates of 60 to 80% at 1 year, roughly double CPAP adherence in real-world settings.¹⁷ The trade-off: MADs are less effective for severe apnea and carry risks of temporomandibular joint discomfort and dental movement if not properly titrated. A 2025 pilot trial of a novel digital MAD with a customized lip bumper found that gradual titration over 4 weeks reduced anterior dental pain from 41% to 12% of users while maintaining efficacy.¹⁵

Comparative effectiveness of four snoring interventions on both partners, based on randomized controlled trials and systematic reviews.

Weight loss for snoring: Evidence is weaker than popular advice suggests

The default advice for snoring is “lose weight.” The clinical trial evidence shows modest efficacy in controlled settings and poor durability in real-world practice, a tension rarely surfaced in consumer health content.

A 2018 randomized controlled trial assigned 57 patients with obesity and obstructive sleep apnea to either a smartphone-guided lifestyle intervention (diet and exercise coaching) or standard care. At 8 weeks, the intervention group lost an average of 4.2 kg and reduced apnea-hypopnea index (AHI, the number of breathing pauses per hour) by 22%. The control group’s weight and AHI did not change.¹⁸

The magnitude matters. A 22% AHI reduction moves a patient from moderate to mild obstructive sleep apnea but does not eliminate the problem. Only 18% of the intervention group achieved an AHI below 5 (the threshold for “normal”), compared to near-100% response rates with CPAP or MADs in the same severity range. The trial also ended at 8 weeks, too short to assess durability. Long-term weight loss maintenance is notoriously difficult: observational studies find that 60 to 80% of individuals regain lost weight within 2 years of a structured intervention.

The snoring-obesity relationship is also non-linear. A 10% weight loss produces larger AHI reductions in individuals with mild obesity (BMI 30 to 35) than in those with severe obesity (BMI above 40), likely because severe obesity involves structural airway changes (fat deposition in the tongue, pharyngeal walls, and abdominal cavity) that do not fully reverse with partial weight loss.²

None of this means weight loss is unhelpful. For individuals with recent weight gain and new-onset snoring, returning to a previous stable weight often resolves symptoms. The tension is between “weight loss cures snoring” (the popular framing) and “weight loss modestly reduces AHI in the short term for selected patients” (the trial evidence). Couples banking on weight loss as the sole intervention often delay more effective treatments for months or years, compounding sleep deprivation and relationship strain.

When to see a doctor: Snoring symptoms that signal sleep apnea

Snoring without apnea (primary snoring) is a nuisance problem that affects the bed partner more than the snorer. Snoring with obstructive sleep apnea is a medical condition that increases cardiovascular, metabolic, and neurocognitive risk. The challenge is distinguishing the two without a sleep study.

Witnessed apneas (the bed partner observes breathing pauses followed by gasping or choking) are the single strongest predictor of obstructive sleep apnea. A systematic review found that witnessed apneas had a positive likelihood ratio of 3.9, meaning the probability of OSA more than triples when this symptom is present.¹ Other high-value symptoms include excessive daytime sleepiness (falling asleep during passive activities like reading or watching TV), morning headaches that resolve within 30 minutes, and nocturia (waking to urinate more than twice per night) in the absence of urological symptoms.

The absence of sleepiness does not rule out sleep apnea. Up to 30% of patients with moderate to severe OSA report minimal daytime sleepiness, likely because chronic sleep fragmentation recalibrates their perceived baseline. Age above 50, neck circumference above 40 cm (men) or 37 cm (women), and hypertension resistant to medication all increase pretest probability enough to warrant a sleep study even without classic symptoms.¹²

The American Academy of Sleep Medicine recommends a diagnostic sleep study (polysomnography or home sleep apnea test) for any adult with habitual snoring plus one or more of the following: witnessed apneas, excessive daytime sleepiness, hypertension, coronary artery disease, atrial fibrillation, type 2 diabetes, or a BMI above 35. The study quantifies apnea severity and guides treatment choice (CPAP vs MAD vs positional therapy).

Where to buy: Mandibular advancement devices for couples

Multiple randomized controlled trials demonstrate that mandibular advancement devices reduce snoring frequency and improve bed partner sleep quality.¹³¹⁴¹⁵ SnoreRX is an adjustable MAD that allows gradual titration (advancing the jaw in 1 mm increments) to find the minimum effective advancement, reducing the risk of temporomandibular joint discomfort while maintaining efficacy.

The adjustability matters for couples: the snorer can calibrate the device over several nights while the partner provides feedback on snoring reduction, turning treatment into a collaborative process rather than an isolated medical intervention. This aligns with the evidence showing that partner engagement predicts adherence.¹⁰

SnoreRX (Adjustable mandibular advancement device, $60). Where to buy →

Disclosure: This is an affiliate link, our only revenue source. We run no display ads and sell no products. We are not affiliated with or endorsed by SnoreRX or any cited organization. Consult a dentist or sleep physician before using a mandibular advancement device if you have temporomandibular joint disorder, loose teeth, or untreated dental disease.